Picture EBD Group BioTech Showcase 2021 Digital Event BTS2021 651x81

News > All

Total search results: 9751 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 80 81 82 ... 96 97 98  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Bruker Corporation. (7/30/12). "Press Release: Bruker Introduces Micro-computed Tomography Accessory for 2D and 3D X-ray Imaging on Scanning Electron Microscopes". Phoenix, AZ. 2012-07-30
Merck Serono. (7/30/12). "Press Release: Merck Serono Announces Creation of First Spin-off Company from Its Entrepreneur Partnership Program. Prexton Therapeutics Will Develop Merck Serono’s Glutamate Receptors Programs for Parkinson’s Disease". Geneva. 2012-07-30
Basilea Pharmaceutica Ltd.. (7/30/12). "Press Release: Basilea Submits European Marketing Authorization Application of Ceftobiprole for the Treatment of Pneumonia". Basel. 2012-07-30
Novartis AG. (7/30/12). "Press Release: Novartis Drug Afinitor Approved by European Commission to Treat Patients with the Most Common Form of Advanced Breast Cancer". Basel. 2012-07-30
High-Tech Gründerfonds Management GmbH. (7/26/12). "Press Release: Investors Realize Exit via Trade Sale of Portfolio Company CorImmun GmbH". Neuss. 2012-07-26
Roche. (7/26/12). "Press Release: FDA Clears Roche’s Vitamin D Laboratory Test. Fully Automated Assay for Widely Available Platforms". Basel. 2012-07-26
Roche. (7/26/12). "Press Release: Roche Posts Strong Operating First-half Results, on Track to Meet 2012 Guidance". Basel. 2012-07-26
Ascenion GmbH. (7/25/12). "Press Release: MHH and Rentschler Sign Licensing Agreement for an Innovative Gene Therapy Vector System. Ascenion Assists the Project from Patenting to Commercialization". Munich, Hannover & Laupheim. 2012-07-25
Bayer AG. (7/25/12). "Press Release: UK’s NICE Recommends Bayer’s Xarelto (Rivaroxaban), the Only Oral Single-drug Therapy for the Treatment of Deep Vein Thrombosis (DVT) and Prevention of Recurrent DVT and Pulmonary Embolism [Not intended for U.S./UK Me 2012-07-25
Evonik Industries AG. (7/25/12). "Press Release: Evonik Invests in Pangaea Ventures Fund III". Essen. 2012-07-25
Qiagen GmbH. (7/25/12). "Press Release: Qiagen Automated Workflow with QIAsymphony RGQ Receives AOAC Validation for Detection of Salmonella in Food Samples". Providence, RI & Hilden. 2012-07-25
Boehringer Ingelheim. (7/25/12). "Press Release: Jentadueto (linagliptin/metformin hydrochloride) Tablets Receive Approval for the Treatment of Adults with Type 2 Diabetes in Europe [for non-U.S. and non-UK Media]". Ingelheim. 2012-07-25
Lonza Group Ltd.. (7/25/12). "Press Release: Lonza Delivered Solid Business Performance in the First Half of 2012". Basel. 2012-07-25
Roche. (7/25/12). "Press Release: Roche Expands Its Blood Screening Portfolio. New Solution Improves Safety of Donated Blood". Rotkreuz & Pleasanton, CA. 2012-07-25
Sartorius AG. (7/25/12). "Press Release: Sartorius Raises Guidance Following Strong First Half. Order Intake and Sales Revenue Up by Double Digits – Earnings-Rise by One-fourth". Göttingen. 2012-07-25
Sartorius AG. (7/25/12). "Press Release: First Half of 2012. SSB Continues on the Growth Track". 2012-07-25
Sygnis Pharma AG. (7/25/12). "Press Release: Sygnis Reports Financial Results for Fiscal Year 2011/12. Strategic Realignment Successfully Initiated". Heidelberg. 2012-07-25
Biofrontera AG. (7/24/12). "Press Release: Biofrontera AG. Distribution Agreement with Spirit Healthcare Lim. for Ameluz in UK and Ireland (Ad hoc Release)". Leverkusen. 2012-07-24
Evonik Industries AG. (7/24/12). "Press Release: Evonik and BioAmber Partner on Catalysts for Sustainable Chemicals Made from Bio-based Succinic Acid". 2012-07-24
Qiagen N.V.. (7/24/12). "Press Release: Qiagen Reports Second Quarter 2012 Results, Raises Full-year Outlook and Announces Share Repurchase Program". Venlo. 2012-07-24
Antisense Pharma GmbH. (7/24/12). "Press Release: Antisense Pharma Receives FDA Orphan Drug Designation for Trabedersen to Treat Malignant Melanoma. TGF-ß2 Inhibitor Has Gained Market Exclusivity in the USA for a Third Aggressive Cancer Indication". Rege 2012-07-24
Stratec Biomedical AG. (7/24/12). "Press Release: Stratec Reports Further Growth. Sales of € 55 Million in Q1–Q2/2012 (+13.3%, Q1–Q2/2011: € 48.5 Million)". Birkenfeld. 2012-07-24
SuppreMol GmbH. (7/24/12). "Press Release: SuppreMol Begins Development of Anti-IL-3 Monoclonal Antibody to Diagnose and Treat Early Stage Rheumatoid Arthritis". Munich. 2012-07-24
Boehringer Ingelheim. (7/23/12). "Press Release: Boehringer Ingelheim and Funxional Therapeutics Announce Acquisition of Funxional’s FX125L and the Somatotaxin Portfolio to Treat Inflammation". Ingelheim & Cambridge. 2012-07-23
Basilea Pharmaceutica Ltd.. (7/23/12). "Press Release: Basilea Announces Completion of Toctino (alitretinoin) Transaction with Stiefel. Basilea Receives GBP 146 Million (approximately CHF 225 Million) Upfront Payment". Basel. 2012-07-23
Illumina, Inc.. (7/23/12). "Press Release: Illumina Countersues IBS and Qiagen for Patent Infringement". San Diego, CA. 2012-07-23
Ruhr-Universität-Bochum. (7/23/12). "Pressemitteilung: Auf dem Weg zum Designerbaby? RUB-Mediziner bezieht Stellung zu Potenzial und Konsequenzen von Genanalysen – Prof. Dr. Jörg Epplen: Keine Garantie für gesunde Kinder". 2012-07-23
Bayer AG. (7/23/12). "Press Release: Phase III Trial Evaluating the Addition of Tarceva (erlotinib) to Nexavar (sorafenib) Did Not Provide Additional Benefit to Patients with Liver Cancer versus Nexavar Alone [Not intended for U.S. and UK Media]". Berlin 2012-07-23
Biofrontera AG. (7/23/12). "Press Release: Biofrontera Discusses Approval of Ameluz in the US with the FDA". Leverkusen. 2012-07-23
Ion Beam Applications S.A. (IBA). (7/23/12). "Press Release: IBA Opens Innovative International Competence Center (ICC) in Germany to Promote Safe and More Efficient Use of Radiation Therapy Dosimetry". Schwarzenbruck (Nuremberg). 2012-07-23
Auxogyn, Inc.. (7/23/12). "Press Release: Auxogyn Receives CE Mark for Non-invasive Early Embryo Viability Assessment (EEVA) Test. Company Launches Eeva Test in the European Union (EU)". Menlo Park, CA. 2012-07-23
Fresenius SE & Co. KGaA. (7/20/12). "Press Release: Fresenius Kabi Acquires Fenwal Holdings, Inc.". Bad Homburg v. d. H.. 2012-07-20
Novartis AG. (7/20/12). "Press Release: Novartis Gains FDA Approval for Afinitor in Advanced Breast Cancer Marking a Significant Milestone for Women Battling this Disease". Basel. 2012-07-20
Novartis AG. (7/19/12). "Press Release: Novartis Second Quarter Results Enhance Future Growth Prospects with Eight Significant Regulatory Milestones, on Track to Deliver 2012 Outlook". Basel. 2012-07-19
Roche. (7/19/12). "Press Release: FDA Clears Accu-Chek Combo System – Roche’s New Interactive Insulin Pump System for People with Diabetes. The System Will Be Available in the United States in the Second Half of 2012". Basel. 2012-07-19
Tecan Group Ltd.. (7/19/12). "Press Release: Powerful Walkaway qPCR Set-up from Tecan. The Roche LC480 Is Linked Directly to the Freedom EVO Workstation". Männedorf. 2012-07-19
Actelion Ltd.. (7/19/12). "Press Release: Actelion Announces Half Year 2012 Financial Results". Allschwil. 2012-07-19
Curetis AG. (7/18/12). "Press Release: Curetis AG Signs Distribution Deal in Middle East with ATC". Holzgerlingen. 2012-07-18
c-LEcta GmbH. (7/18/12). "Press Release: Aquapharm and c-LEcta to Drive Forward Discovery and Commercialisation of Marine-derived Biocatalysts". 2012-07-18
Paion AG. (7/18/12). "Press Release: Paion AG Grants License to Yichang Humanwell for Remimazolam in China. Paion Receives EUR 3 Million Upfront Payments". Aachen. 2012-07-18
Bayer AG. (7/18/12). "Press Release: Bayer HealthCare Receives Orphan Drug Designation for Its Anti-cancer Agent in the U.S. for the Treatment of Mesothelioma [Not intended for UK and US Media]". Berlin. 2012-07-18
Roche. (7/18/12). "Press Release: Roche Introduces Mobile Blood Gas Analyzer for Hospital Point-of-Care Testing in the United States. FDA Approval Grants Immediate Marketing of the cobas b 123 POC System in the U.S.". Rotkreuz. 2012-07-18
Sygnis Pharma AG. (7/18/12). "Press Release: Sygnis and Genetrix Announce Proposed Combination of Businesses of Sygnis and Genetrix’ Subsidiary X-Pol". Heidelberg. 2012-07-18
4SC AG. (7/17/12). "Press Release: 4SC Discovery, Crelux and Ribological Launch Collaboration for the Discovery and Optimisation of New Anti-cancer Drugs [no US". Planegg-Martinsried. 2012-07-17
Biobase GmbH. (7/17/12). "Press Release: Luxembourg Centre for Systems Biomedicine Appoints Biobase Genome Trax to Identify Human Genome Variations". Wolfenbüttel. 2012-07-17
ADC Therapeutics S.a.r.l.. (7/17/12). "Press Release: ADC Therapeutics Appoints Former Genmab VP Dr Patrick van Berkel as Senior VP of R&D". Lausanne. 2012-07-17
Sartorius AG. (7/17/12). "Press Release: One Does It All. Sartorius Stedim Biotech Unveils a New Generation of Its Successful Laboratory Bioreactor Series Biostat B". Göttingen. 2012-07-17
Biotest AG. (7/16/12). "Press Release: Biotest AG Starts Combination Therapy Study with BT-062 in Multiple Myeloma. Antibody-drug Conjugate BT-062 Continues to Show Good Tolerability in Monotherapy". Dreieich. 2012-07-16
Genetrix S.L.. (7/16/12). "Press Release: Genetrix Licenses »Qualiphi« Polymerase to Qiagen. Genetrix’s First Global License Agreement". Madrid. 2012-07-16
Innovationsstarter Hamburg GmbH. (7/16/12). "Pressemitteilung: Innovationsstarter Fonds Hamburg investiert in Xtal Concepts". Hamburg. 2012-07-16
High-Tech Gründerfonds Management GmbH. (7/16/12). "Press Release: Subitec GmbH Raises 4.5m Euros in Second Round Financing". Münster, Stuttgart, Bonn & Munich. 2012-07-16
Genedata AG. (7/16/12). "Press Release: Genedata Biologics Releases Advanced Support for High-throughput Protein Expression Workflows". Basel. 2012-07-16
BioKryo GmbH. (7/16/12). "Press Release: BioKryo Joins BIO Deutschland". 2012-07-16
Actelion Ltd.. (7/12/12). "Press Release: Actelion Announces Cost Saving Initiative to Be Implemented by the End of 2012. Initative Could Result in a Reduction of Up to 135 Positions". Allschwil. 2012-07-12
Bayer AG. (7/12/12). "Press Release: Kogenate Bayer Was Effective in Reducing Bleeding Frequency when Used as Secondary Prophylaxis in Adults with Severe Hemophilia A [Not intended for U.S. and UK Media]". Berlin. 2012-07-12
Labor Diagnostik GmbH Leipzig (LDL). (7/12/12). "Press Release: Qiagen and Labor Diagnostik Leipzig Join Forces to Offer Complete Veterinary Testing Portfolio". 2012-07-12
Wilex AG. (7/12/12). "Press Release: Wilex Announces Results of Successful First Half Year 2012". Munich. 2012-07-12
High-Tech Gründerfonds Management GmbH. (7/11/12). "Press Release: Epigenetics Specialist Epivios Financed by High-Tech Gründerfonds and Life Science Inkubator’s Pre-seed Fund". Bonn & Düsseldorf. 2012-07-11
Noxxon Pharma AG. (7/11/12). "Press Release: Noxxon Initiates Phase IIa of anti-CXCL12/SDF-1 Spiegelmer NOX-A12 for Treatment of Chronic Lymphocytic Leukemia". Berlin. 2012-07-11
Genedata AG. (7/11/12). "Press Release: Takeda Selects Genedata Expressionist for Genomic Profiling". Tokyo. 2012-07-11
Evotec AG. (7/10/12). "Press Release: CureBeta, a Collaboration between Evotec and Harvard University, Enters Strategic Alliance with Janssen Pharmaceuticals". Hamburg. 2012-07-10
Mologen AG. (7/10/12). "Press Release: Mologen AG Capital Increase. Proceeds of 22 Million EUR". 2012-07-10
Bayer AG. (7/10/12). "Press Release: Bayer Announces 2012 Recipients of Bayer Hemophilia Awards Program [Not intended for U.S. and UK Media]". Berlin. 2012-07-10
MPM Capital. (7/10/12). "Press Release: Dr. Mirko Scherer and Sebastian Meier-Ewert, Ph.D., Join MPM Senior Investment Team". Boston, MA & South San Francisco, CA. 2012-07-10
Metabolon, Inc.. (7/10/12). "Press Release: Metabolon Technology Now Available in Germany with Validation of Helmholtz Zentrum München Laboratory". Research Triangle Park, NC. 2012-07-10
Boehringer Ingelheim. (7/10/12). "Press Release: Boehringer Ingelheim Pursuing Health Care Innovation – New Collaboration with Healthrageous, Inc on a Digital Diabetes Self-management Program". 2012-07-10
Lonza Group Ltd.. (7/10/12). "Press Release: Lonza Launches Next Generation GS Gene Expression System. The New GS Xceed Gene Expression System Provides Up to a 6 Week Reduction in Cell Line Construction". Basel. 2012-07-10
Two Blades Foundation. (7/9/12). "Press Release: Two Blades Foundation Licenses Genome Engineering Technology to KWS". Evanston, IL. 2012-07-09
Bayer AG. (7/9/12). "Press Release: Bayer’s Xarelto (rivaroxaban) Granted Priority Review by U.S. FDA for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism and the Long-term Prevention of Recurrent Venous Thromboembolism". Berlin. 2012-07-09
Horizon Discovery Ltd.. (7/9/12). "Press Release: Horizon Discovery and Bayer Collaborate to Develop Cell Line Models to Support Oncology Programs". Cambridge. 2012-07-09
Genkyotex S.A.. (7/9/12). "Press Release: Genkyotex Closes CHF25 Million (USD26 Million) Extension to Its Series C Financing". Geneva & Archamps. 2012-07-09
CellGenix GmbH. (7/9/12). "Press Release: CellGenix, a Leading Supplier of GMP Cytokines and Specialized Serum-free Media, Received ISO 9001:2008 Certification". Freiburg. 2012-07-09
Boehringer Ingelheim. (7/9/12). "Press Release: Boehringer Ingelheim Establishes Translational Research Collaboration with Harvard University in Areas of Unmet Medical Need". Ingelheim. 2012-07-09
Paion AG. (7/9/12). "Press Release: Preclinical Efficacy of Solulin in Radiation Injury Confirmed in US/German Research Collaboration and Published in »Nature Medicine«". Aachen. 2012-07-09
PolyQuant GmbH. (7/9/12). "Press Release: New QconCAT Kits for Absolute Protein Quantification with Mass Spectrometry". 2012-07-09
Galenica Holding AG. (7/9/12). "Press Release: PA21 – Pivotal Phase III Study Met Primary and Secondary Endpoints. Preparations for Regulatory Filings Are Underway". 2012-07-09
Reinnervate Ltd.. (7/9/12). "Press Release: Medicyte GmbH and Reinnervate Ltd to Collaborate on Development of Next Generation Predictive 3D Cell Toxicity Assays". Sedgefield. 2012-07-09
Bayer AG. (7/8/12). "Press Release: Bayer Initiates Phase III Trial of New Recombinant Factor VIII Compound for Treatment of Hemophilia. BAY94-9027 Being Investigated for Prolonged Duration of Effect and Less Frequent Infusions". Berlin. 2012-07-08
Anagnostics Bioanalysis GmbH. (7/6/12). "Press Release: Anagnostics and Molzym Form Strategic Allianc Fighting Sepsis. Novel Integrated Sepsis Diagnostics". 2012-07-06
Qiagen N.V.. (7/6/12). "Press Release: Qiagen Achieves Personalized Healthcare Milestone with U.S. Approval of Companion Diagnostic for Colorectal Cancer. U.S. Launch therascreen KRAS RGQ PCR Kit [incl. Appendix on Personalised Medicine]". Hilden & Germa 2012-07-06
Celtic Therapeutics Management L.L.L.P.. (7/6/12). "Press Release: Cancer Research Technology and ADC Therapeutics Join Forces on Antibody Drug Conjugates". London & Lausanne. 2012-07-06
Medigene AG. (7/6/12). "Press Release: Medigene and SynCore Enter into Co-development and Commercialization Agreement for EndoTAG-1". Martinsried/Munich. 2012-07-06
Anagnostics Bioanalysis GmbH. (7/5/12). "Press Release: New Distribution Partner in Austria". 2012-07-05
Berthold Technologies GmbH & Co. KG. (7/5/12). "Press Release: Berthold Launches TriStar² Microplate Reader". Bad Wildbad. 2012-07-05
Boehringer Ingelheim. (7/5/12). "Press Release: Boehringer Ingelheim Announces Changes to Board of Management Directors. Joachim Hasenmaier to Lead New Board Division Consumer Healthcare and Animal Health". 2012-07-05
Ion Beam Applications S.A. (IBA). (7/5/12). "Press Release: Trading Update. Letter of Intent Signed for Sale of IBA Molecular Business in Canada for approx. EUR 11 Million – Good Progress on Settlement of Essen Project Litigation". Louvain-la-Neuve. 2012-07-05
Merck Serono. (7/5/12). "Press Release: Merck Serono. EXPAND Trial of Erbitux in Advanced Gastric Cancer Does Not Meet Primary Endpoint". Darmstadt. 2012-07-05
Merck Serono. (7/5/12). "Press Release: Merck Serono. Worldwide Development and Commercialization Agreement with MDxHealth for MGMT Diagnostic Test". Darmstadt. 2012-07-05
MorphoSys AG. (7/5/12). "Press Release: MorphoSys Partner OncoMed Publishes Data on HuCAL Antibody OMP-18R5. Preclinical Data Published in PNAS Demonstrates Potent Anti-cancer Activity of Antibody Targeting Wnt Pathway". 2012-07-05
Roche. (7/5/12). "Press Release: Roche Complements Hemostasis Portfolio with the Multiplate Analyzer. Personalized Anti-platelet Therapy and Stratified Bleeding Risk with Unique Diagnostic Solution". Rotkreuz. 2012-07-05
Shimadzu Corporation. (7/4/12). "Press Release: Shimadzu Presentation Digest at TIAFT". 2012-07-04
Bernhard-Nocht-Institut. (7/4/12). "Pressemitteilung: Gemeinsam gegen Infektion. Millionenförderung für die Infektionsforschung in der Metropolregion Hamburg". Hamburg, Borstel & Lübeck. 2012-07-04
Leukocare AG. (7/4/12). "Press Release: Leukocare Provides Key Technologies for Tumour Diagnosis in Personalized Medicine Research Project. Multi-national Consortium Receives €6 Million EU Grant". Munich. 2012-07-04
Sony DADC. (7/3/12). "Press Release: Sony DADC BioSciences to Develop Smart Consumables for Next Generation of Sony Cell Sorting Instrumentation System". Salzburg. 2012-07-03
Addex Therapeutics S.A.. (7/3/12). "Press Release: Addex Appoints Dr. Graham Dixon as Chief Scientific Officer and Head of Research". Geneva. 2012-07-03
Bayer AG. (7/3/12). "Press Release: Bayer CropScience Acquires US-based Biological Company AgraQuest for Close to US$ 500 Million. Further Milestone to Strengthen the Fruits and Vegetables Business". Monheim. 2012-07-03
Taylor Wessing. (7/3/12). "Pressemitteilung: Taylor Wessing berät Euroimmun beim Erwerb des brasilianischen Diagnostikunternehmens GMK". 2012-07-03
Scienion AG. (7/2/12). "Press Release: Novel Lectin-based Microarrays for Analyses of Glycosylation Structures. Procognia Microarray Production Based on Scienion’s sciFlexarrayer Technology". Dortmund & Berlin. 2012-07-02
Bayer AG. (7/2/12). "Press Release: Bayer to Present Data Hemophilia Research at the WFH 2012 World Congress. SPINART Phase III Clinical Data – BAY 94-9027 Phase I Clinical Trial Data". Berlin. 2012-07-02
Paion AG. (7/2/12). "Press Release: Paion Deutschland GmbH Receives a Grant Worth EUR 0.7 Million from the Federal Ministry of Education and Research (BMBF) for Research into the Potential of Thrombomodulin-Mutants". Aachen. 2012-07-02
next pagenext page 1 2 3 ... 80 81 82 ... 96 97 98  next pagenext page


Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture [iito] Made Without Love 650x80px

» top